Ferrari, G., Pollara, J., Kozink, D., Harms, T., Drinker, M., Freel, S., … Haynes, B. F. (2011). Mapping of ADCC Activity: The A32 Conformational C1 Epitope is a Dominant Target for ADCC Antibodies in Chronically HIV-1 Infected Subjects. In AIDS RESEARCH AND HUMAN RETROVIRUSES (Vol. 27, pp. A66–A66). Bangkok, THAILAND: MARY ANN LIEBERT INC.

Ferrari, G., J. Pollara, D. Kozink, T. Harms, M. Drinker, S. Freel, M. A. Moody, et al. “Mapping of ADCC Activity: The A32 Conformational C1 Epitope is a Dominant Target for ADCC Antibodies in Chronically HIV-1 Infected Subjects.” In AIDS RESEARCH AND HUMAN RETROVIRUSES, 27:A66–A66. MARY ANN LIEBERT INC, 2011.

Ferrari G, Pollara J, Kozink D, Harms T, Drinker M, Freel S, et al. Mapping of ADCC Activity: The A32 Conformational C1 Epitope is a Dominant Target for ADCC Antibodies in Chronically HIV-1 Infected Subjects. In: AIDS RESEARCH AND HUMAN RETROVIRUSES. MARY ANN LIEBERT INC; 2011. p. A66–A66.

Ferrari, G., et al. “Mapping of ADCC Activity: The A32 Conformational C1 Epitope is a Dominant Target for ADCC Antibodies in Chronically HIV-1 Infected Subjects.” AIDS RESEARCH AND HUMAN RETROVIRUSES, vol. 27, no. 10, MARY ANN LIEBERT INC, 2011, pp. A66–A66.

Ferrari G, Pollara J, Kozink D, Harms T, Drinker M, Freel S, Moody MA, Tomaras GD, Ochsenbauer C, Kappes JC, Shaw GM, Hoxie JA, Robinson JE, Montefiori DC, Haynes BF. Mapping of ADCC Activity: The A32 Conformational C1 Epitope is a Dominant Target for ADCC Antibodies in Chronically HIV-1 Infected Subjects. AIDS RESEARCH AND HUMAN RETROVIRUSES. MARY ANN LIEBERT INC; 2011. p. A66–A66.